Azenosertib
ZN-c3-002
Phase 1 small_molecule active
Quick answer
Azenosertib for Solid Tumor is a Phase 1 program (small_molecule) at Zentalis Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active